NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
TOUR
Tuniu Corporation
There isn't enough reported data to score TOUR yet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
TOUR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
TOUR's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
TOUR PE Valuation
TOUR has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
TOUR Forward outlook
There aren't enough analyst estimates for TOUR to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
TOUR Earnings Per Share
TOUR and NIO do not have enough comparable growth data to identify a winner.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over TOUR on profitability, with a higher operating margin.
TOUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $19.9M | +13% |
| Q4 2025 | $18.5M | +20% |
| Q3 2025 | $30.3M | +8.6% |
| Q2 2025 | $20.2M | +15% |
| Q1 2025 | $17.6M | +8.9% |
| Q4 2024 | $15.4M | +2.8% |
| Q3 2024 | $27.9M | +4.4% |
| Q2 2024 | $17.5M | +17% |
TOUR's revenue has grown year over year for 13 quarters in a row: $20M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -2.8% | +6.4 points |
| Q4 2025 | 0.9% | +13 points |
| Q3 2025 | 6.8% | -8.8 points |
| Q2 2025 | 5.3% | -24 points |
| Q1 2025 | -9.2% | -21 points |
| Q4 2024 | -12% | +111 points |
| Q3 2024 | 16% | -2.1 points |
| Q2 2024 | 29% | +23 points |
TOUR's operating margin was −2.8% last quarter, up 6.4 points from the same quarter a year ago.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with TOUR at down 100%.
TOUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | -100% |
| Q2 2024 | $0 | -100% |
| Q1 2024 | $0 | -100% |
| Q4 2023 | $0 | -100% |
| Q3 2023 | $250.5K | -44% |
TOUR's free cash flow has been positive every quarter since mid-2020: $0 over the past year, against $250,463 the year before.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
TOUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.3% | -88.5K shares |
| 1 year | -5.8% | -230K shares |
TOUR has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TOUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.8x | Net Cash |
| Q4 2025 | -3.2x | Net Cash |
| Q3 2025 | -34.6x | Net Cash |
| Q2 2025 | -14.7x | Net Cash |
| Q1 2025 | -16.8x | Net Cash |
| Q4 2024 | -5.9x | Net Cash |
| Q3 2024 | -3.8x | Net Cash |
| Q2 2024 | -6.7x | Net Cash |
TOUR has more cash than debt.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
TOUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 12.5 | Oversold |
TOUR's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
TOUR PE vs Consumer Cyclical Sector
TOUR has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
TOUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.86 | 3.5% below |
| 20 week MA | $4.95 | 5.3% below |
| 50 week MA | $5.94 | 21% below |
| 100 week MA | $7.53 | 38% below |
| 200 week MA | $9.63 | 51% below |
TOUR is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
TOUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $19.2 | -18% |
| 2021 | $19.2 | $9.78 | -49% |
| 2022 | $9.78 | $16.7 | +71% |
| 2023 | $16.7 | $6.71 | -60% |
| 2024 | $6.71 | $9.85 | +47% |
| 2025 | $9.85 | $7.25 | -26% |
| 2026 YTD | $7.25 | $4.69 | -35% |
TOUR has the edge over NIO on returns for 2026, with the stronger performance.